New hope for kids with devastating brain cancers: targeted drug trial launches
NCT ID NCT07206849
Summary
This study is testing whether a drug called tovorafenib can help children and young adults live longer after being diagnosed with aggressive brain tumors, including a type called DIPG. The drug is given after standard radiation treatment and targets tumors with specific genetic changes. The main goal is to see if it can delay the cancer's return and improve survival compared to past treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.